Key drivers for each region include: for North America, high adoption of uroflowmeters, significant investments in research and development, and favorable policies; for Europe, increasing demographics, growing ecosystem maturity, and rising adoption of advanced medical devices; for Asia Pacific, large demographics, improving infrastructure, and growing investments in healthcare; for Latin America, increasing adoption of uroflowmeters, improving infrastructure, and favorable policies; and for Middle East & Africa, growing ecosystem maturity, increasing investments in healthcare, and rising adoption of advanced medical devices.